Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
115,468,014
-
Share change
-
-1,352,313
-
Total reported value
-
$20,442,238,689
-
Put/Call ratio
-
107%
-
Price per share
-
$177.10
-
Number of holders
-
436
-
Value change
-
-$245,878,270
-
Number of buys
-
186
-
Number of sells
-
213
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2023
As of 30 Sep 2023,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
436 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,468,014 shares.
The largest 10 holders included
Capital World Investors, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., BAILLIE GIFFORD & CO, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Dodge & Cox, T. Rowe Price Investment Management, Inc., and Capital International Investors.
This page lists
443
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.